Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells

  • Gener, P.
  • Montero, S.
  • Xandri-Monje, H.
  • Díaz-Riascos, Z.V.
  • Rafael, D.
  • Andrade, F.
  • Martínez-Trucharte, F.
  • González, P.
  • Seras-Franzoso, J.
  • Manzano, A.
  • Arango, D.
  • Sayós, J.
  • Abasolo, I.
  • Schwartz, S.Jr
Tumor recurrence, metastatic spread and progressive gain of chemo-resistance of advanced cancers are sustained by the presence of cancer stem cells (CSCs) within the tumor. Targeted therapies with the aim to eradicate these cells are thus highly regarded. However, often the use of new anti-cancer therapies is hampered by pharmacokinetic demands. Drug delivery through nanoparticles has great potential to increase efficacy and reduce toxicity and adverse effects. However, its production has to be based on intelligent design. Likewise, we developed polymeric nanoparticles loaded with Zileuton™, a potent inhibitor of cancer stem cells (CSCs), which was chosen based on high throughput screening. Its great potential for CSCs treatment was subsequently demonstrated in in vitro and in in vivo CSC fluorescent models. Encapsulated Zileuton™ reduces amount of CSCs within the tumor and effectively blocks the circulating tumor cells (CTCs) in the blood stream and metastatic spread.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

  • Rafael, Diana|||0000-0003-3180-3028
  • Gener, Petra|||0000-0002-2250-570X
  • Andrade, Fernanda|||0000-0002-4947-2346
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Montero, Sara
  • Fernández Caparrós, Yolanda
  • Hidalgo, Manuel|||0000-0002-3765-3318
  • Arango, Diego|||0000-0003-2953-3284
  • Florindo, Helena F.
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Schwartz, Simon|||0000-0001-8297-7971
  • Videira, Mafalda
Development of RNA interference-based therapies with appropriate therapeutic window remains a challenge for advanced cancers. Because cancer stem cells (CSC) are responsible of sustaining the metastatic spread of the disease to distal organs and the progressive gain of resistance of advanced cancers, new anticancer therapies should be validated specifically for this subpopulation of cells. A new amphihilic-based gene delivery system that combines Pluronic ® F127 micelles with polyplexes spontaneously formed by electrostatic interaction between anionic siRNA and cationic polyethylenimine (PEI) 10K, was designed (PM). Resultant PM gather the requirements for an efficient and safe transport of siRNA in terms of its physicochemical characteristics, internalization capacity, toxicity profile and silencing efficacy. PM were loaded with a siRNA against AKT2, an important oncogene involved in breast cancer tumorigenesis, with a special role in CSC malignancy. Efficacy of siAKT2-PM was validated in CSC isolated from two breast cancer cell lines: MCF-7 and Triple Negative MDA-MB-231 corresponding to an aggressive subtype of breast cancer. In both cases, we observed significant reduction on cell invasion capacity and strong inhibition of mammosphere formation after treatment. These results prompt AKT2 inhibition as a powerful therapeutic target against CSC and pave the way to the appearance of more effective nanomedicine-based gene therapies aimed to prevent CSC-related tumor recurrence.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dynamism, Sensitivity, and Consequences of Mesenchymal and Stem-Like Phenotype of Cancer Cells

  • Gener, Petra|||0000-0002-2250-570X
  • Seras-Franzoso, Joaquin|||0000-0002-7893-4773
  • Callejo, Patricia González
  • Andrade, Fernanda|||0000-0002-4947-2346
  • Rafael, Diana|||0000-0003-3180-3028
  • Martínez, Francesc
  • Montero, Sara
  • Arango, Diego|||0000-0003-2953-3284
  • Sayós, Joan|||0000-0002-4664-3461
  • Abasolo, Ibane|||0000-0001-5970-6276
  • Schwartz, Simon|||0000-0001-8297-7971
There are remarkable similarities in the description of cancer stem cells (CSCs) and cancer cells with mesenchymal phenotype. Both cell types are highly tumorigenic, resistant against common anticancer treatment, and thought to cause metastatic growth. Moreover, cancer cells are able to switch between CSC and non-CSC phenotypes and vice versa, to ensure the necessary balance within the tumor. Likewise, cancer cells can switch between epithelial and mesenchymal phenotypes via well-described transition (EMT/MET) that is thought to be crucial for tumor propagation. In this review, we discuss whether, and to which extend, the CSCs and mesenchymal cancer cells are overlapping phenomena in terms of mechanisms, origin, and implication for cancer treatment. As well, we describe the dynamism of both phenotypes and involvement of the tumor microenvironment in CSC reversion and in EMT.